SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ -- At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr. Jarrod Frizzell of The…
New data demonstrate amivantamab combination significantly reduces common EGFR and MET resistance mutations seen with EGFR TKIs1 BEERSE, BELGIUM ,…
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or…
--Genius Tracker TF™ now accommodates up to 1.7° post-to-post, enabling the industry's lowest grading requirement on challenging terrain-- NORWALK, Conn., July…
The company's 2024 Sustainability Report highlights emissions reduction and progress toward its CN2030 goals MELVILLE, N.Y., June 26, 2025 /PRNewswire/…
New solution improves protocol design, reduces patient- and site-burden, accelerates recruitment, and delivers increased efficiencies for clinical trials SINGAPORE, June…